Pillar Biosciences

About:

Pillar Biosciences specializes in sequencing technology platform and proprietary data analysis toolkit.

Website: http://www.pillar-biosciences.com

Twitter/X: Pillar_Bio

Top Investors: ZhenFund, ORI Capital, HB Ventures

Description:

Pillar Biosciences is prized with its patent-pending targeted sequencing technology platform and a proprietary data analysis toolkit, which achieves high sensitivity and specificity with clinical samples. The platform provides a fast, simple and affordable targeted sequencing method for NGS-based oncology testing. The start-up has also released its beta version of Lung & Colon Cancer Somatic Mutation Panel and BRCA1 & BRCA2 Germline Mutation Panel to cancer centers and clinical testing companies in the US and China for validation studies. The company was founded in 2014 and is headquartered in Natick, Massachusetts.